CSIMarket
 


Regencell Bioscience Holdings Limited  (RGC)
Other Ticker:  
 

Regencell Bioscience Holdings Limited's Long Term Debt to Equity

RGC's quarterly Long Term Debt to Equity and Long Term Debt, Equity growth


In the forth quarter 2023 Regencell Bioscience Holdings Limited did not have Long Term Debt.

Within Legal Cannabis industry Regencell Bioscience Holdings Limited achieved the lowest Long Term Debt to Equity in the forth quarter 2023. While total ranking remained the same in the forth quarter 2023 compared to the previous quarter at no. .

Explain Long Term Debt to Equity Ratio?
How much Long Term Debt RGC´s has?
What is the structure of RGC´s Equity?


RGC Long Term Debt to Equity (Jun 30 2023)
IV. Quarter
0
III. Quarter
0
II. Quarter
0
I. Quarter
(Jun 30 2022)
IV. Quarter
Y / Y Equity Change -29.81 % -29.81 % -29.81 % -29.81 % -
Y / Y Long Term Debt Change - - - - -
Long Term Debt to Equity MRQ - - - - -
RGC's Total Ranking # # # # #
Seq. Equity Change 0 % 0 % 0 % -29.81 % 0 %
Seq. Long Term Debt Change - - - - -



Long Term Debt to Equity forth quarter 2023 Company Ranking
Within: No.
Legal Cannabis Industry #
Consumer Non Cyclical Sector #
Overall Market #


Long Term Debt to Equity Statistics
High Average Low
0 0 0
 




Financial Statements
Regencell Bioscience Holdings Limited's Equity $ 12 Millions Visit RGC's Balance sheet
Regencell Bioscience Holdings Limited's Long Term Debt $ 0 Millions Visit RGC's Balance sheet
Source of RGC's Sales Visit RGC's Sales by Geography


Cumulative Regencell Bioscience Holdings Limited's Long Term Debt to Equity

RGC's Long Term Debt to Equity for the trailling 12 Months

RGC Long Term Debt to Equity

(Jun 30 2023)
IV. Quarter
0
III. Quarter
0
II. Quarter
0
I. Quarter
(Jun 30 2022)
IV. Quarter
Y / Y Equity TTM Growth -29.81 % -29.81 % -29.81 % -29.81 % -
Y / Y Long Term Debt TTM Growth - - - - -
Long Term Debt to Equity TTM - - - - -
Total Ranking TTM
Seq. Equity TTM Growth 0 % 0 % 0 % -29.81 % 0 %
Seq. Long Term Debt TTM Growth - - - - -


On the trailing twelve months basis During the twelve months ending IV Quarter 2023 Regencell Bioscience Holdings Limited did not have Long Term Debt .
Long Term Debt to Equity is the average cumulative value over the last four quarters.

Among companies in the Legal Cannabis industry RGC recorded the lowest Long Term Debt to Equity. While total ranking remained unchanged compared to previous 12 month period at no. 0.

Explain Long Term Debt to Equity Ratio?
How much Long Term Debt RGC´s has?
What is the structure of RGC´s Equity?

TTM Long Term Debt to Equity Company Ranking
Within: No.
Within the Legal Cannabis Industry #
Consumer Non Cyclical Sector #
Within the Market #


trailing twelve months Long Term Debt to Equity Statistics
High Average Low
0 0 0
 




Companies with similar Long Term Debt to Equity in the quarter ending Jun 30 2023, within Legal Cannabis Industry Long Term Debt to EquityJun 30 2023 MRQ Long Term DebtJun 30 2023 MRQ Equity

Date modified: 2023-10-28T10:04:47+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com